The Heme Degradation Pathway is a Promising Serum Biomarker Source for the Early Detection of Alzheimer's Disease - Mueller, Claudius; Zhou, Weidong; VanMeter, Amy; Heiby, Michael; Magaki, Shino; Ross, Mark M.; Espina, Virginia; Schrag, Matthew; Dickson, Cindy; Liotta, Lance A.; Kirsch, Wolff M. (Journal of Alzheimer's disease, 2010)
Keywords: Aged; Aged, 80 and over; Alzheimer Disease - metabolism; Alzheimer Disease - pathology; Biomarkers; Cognition Disorders - diagnosis; Diagnosis, Differential; Female; Heme Oxygenase-1 - metabolism; Humans; Male; Mass Spectrometry; Matrix Metalloproteinase 9 - metabolism; Neuropsychological Tests; Phospholipase D - metabolism; Protein Array Analysis; Severity of Illness Index; prosaposin; phospholipase D1; heme; heme oxyengase-1; BLVR; biomarker; serum; Alzheimer's disease; complement factor H; BVR; S100A7